CHMP recommends expansion of EU label for Hemlibra to include people with moderate haemophilia A December 16, 2022January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: European Commission approves label expansion of…Interim data from phase III HAVEN 6 study…New data from phase III HAVEN 6 study reinforce…CHMP recommends EU approval of Roche’s Polivy…CHMP recommends EU approval of Roche’s Tecentriq as…CHMP recommends EU conditional approval of Roche’s…
